Manuel Medarde

Manuel Medarde


Research Focus & Metrics

Academic Career Length

49Years (1978-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2000 in Molecules
Verified
Journal Article
Open access
PDF file
CMConcepción P. Melero
Concepción P. Melero
MMManuel Medarde
Manuel Medarde
AFArturo San Feliciano
Arturo San Feliciano
A short review on cardiotonic steroids and their analogues is presented. The natural, semisynthetic and synthetic derivatives, as well as their mechanism of action and structure-activity relationships are shown, with a special reference to aminoguanidine derivatives.

31 December 2004 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
AMAna B. S. Maya
Ana B. S. Maya
CPConcepción Pérez-Melero
Concepción Pérez-Melero
CMCarmen Mateo
Carmen Mateo
DADulce Alonso
Dulce Alonso
JFJosé Luis Fernández
José Luis Fernández
MMManuel Medarde
Manuel Medarde

1 July 2004 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
CPConcepción Pérez-Melero
Concepción Pérez-Melero
AMAna B.S Maya
Ana B.S Maya
BRBenedicto del Rey
Benedicto del Rey
RPRafael Peláez
Rafael Peláez
ECEsther Caballero
Esther Caballero
MMManuel Medarde
Manuel Medarde

20 March 2013 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
RARaquel Alvarez
Raquel Alvarez
PPPilar Puebla
Pilar Puebla
JJosé Fernando Díaz
José Fernando Díaz
ABAna C. Bento
Ana C. Bento
RGRósula García-Navas
Rósula García-Navas
RPRafael Peláez
Rafael Peláez

1 December 2004 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
MMManuel Medarde
Manuel Medarde
AMAna B.S. Maya
Ana B.S. Maya
CPConcepción Pérez-Melero
Concepción Pérez-Melero
Synthesis and evaluation of new combretastatin analogues with varied modifications on the bridge and the aromatic rings, have shown that the 2-naphthyl moiety is a good surrogate for the 3-hydroxy-4-methoxyphenyl (B-ring) of combretastatin A-4. Other bicyclic systems, such as 6(7)-quinolyl and 5-indolyl, can replace the B-ring, but they produce less potent analogues in the cytotoxicity and tubulin polymerization inhibition assays. Other modifications are detrimentral for the potency of the studied analogues. The 2-naphthyl combretastatin 53 and the related 6-quinolyl combretastatin 106 analogues are the most potent among the derivatives of this type, whereas 92 and 95 are the most potent among the naphthalene derivatives with a heterocycle in the bridge. Previous and new results in this family of combretastatin analogues are discussed.

1 January 1989 in Phytochemistry
Verified
Journal Article
Closed access
AFArturo San Feliciano
Arturo San Feliciano
MMManuel Medarde
Manuel Medarde
MGMarina Gordaliza
Marina Gordaliza
EOEsther Del Olmo
Esther Del Olmo
JCJosé M. Miguel del Corral
José M. Miguel del Corral